Genedata Expands Collaboration with HepatoSys Systems Biology Network
Genedata AG announced a three-year expansion of their collaboration with the HepatoSys research network. HepatoSys, an interdisciplinary initiative funded in 2003 by leading German research centers, aims to understand the physiology and pathophysiology of the human liver cell using a systems biology approach.
In the first funding period of HepatoSys, Genedata had been tasked to develop and establish a computational platform serving as the consortium's central data storage and analysis infrastructure. The platform was successfully deployed and is now being used by the consortium. The centralized data storage infrastructure enables an integrative approach to the interpretation of systems biology modeling results in the context of experimental findings, including high-throughput transcriptomics, proteomics and metabolomics data.
Taking the collaboration to the next level, Genedata will now work on data analysis projects to interpret the huge amounts of molecular profiling data generated within the HepatoSys consortium.
"The ambitous goal to simulate complex biochemical networks and their regulation in liver cells is highly relevant for innovative biomedical applications," explained Prof. Irmgard Merfort, Institute for Pharmaceutical Sciences, University of Freiburg. "Cellular processes such as programmed cell death and regeneration of liver cells are of great scientific and medical interest. Genedata will help us to identify new biomarkers for disease diagnostics and to pave the way for novel therapeutic approaches in tissue regeneration, cancer and inflammation."
Other news from the department science
Most read news
More news from our other portals
See the theme worlds for related content
Last viewed contents
Successful Third Year Field Trial of Evogene's Candidate Gene for Improving Yield and Abiotic Stress Tolerance - Three years of field trials of Evo133 consistently demonstrate yield increases of up to 25% under normal conditions and up to 20% under abiotic stress conditions
Vaccination as simple as putting on lotion - Nanotechnology lets vaccines get into the body without a pinprick
Observed live for the first time: photocatalysts switch off a virus - Whitening agent titanium dioxide kills viruses – now researchers see it at work at the nanoscale
Galapagos and Roche expand COPD alliance
PupPharma moves into the Biocitech science park
